BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12031672)

  • 21. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multicatalytic proteinase (prosome, proteasome): comparison of the eukaryotic and archaebacterial enzyme.
    Dahlmann B; Kopp F; Kuehn L; Hegerl R; Pfeifer G; Baumeister W
    Biomed Biochim Acta; 1991; 50(4-6):465-9. PubMed ID: 1801710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple associated proteins regulate proteasome structure and function.
    Leggett DS; Hanna J; Borodovsky A; Crosas B; Schmidt M; Baker RT; Walz T; Ploegh H; Finley D
    Mol Cell; 2002 Sep; 10(3):495-507. PubMed ID: 12408819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered proteasome function and subunit composition in aged muscle.
    Husom AD; Peters EA; Kolling EA; Fugere NA; Thompson LV; Ferrington DA
    Arch Biochem Biophys; 2004 Jan; 421(1):67-76. PubMed ID: 14678786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of C-terminal extensions of subunits beta2 and beta7 in assembly and activity of eukaryotic proteasomes.
    Ramos PC; Marques AJ; London MK; Dohmen RJ
    J Biol Chem; 2004 Apr; 279(14):14323-30. PubMed ID: 14722099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-protein interactions among human 20S proteasome subunits and proteassemblin.
    Jayarapu K; Griffin TA
    Biochem Biophys Res Commun; 2004 Feb; 314(2):523-8. PubMed ID: 14733938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and properties of the 26S protease complex from chick skeletal muscle.
    Lee DH; Kim SS; Kim KI; Ahn JY; Shim KS; Nishigai M; Ikai A; Tamura T; Tanaka K; Ichihara A
    Biochem Mol Biol Int; 1993 May; 30(1):121-30. PubMed ID: 8358324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biogenesis of eukaryotic 20S proteasomes: the complex maturation pathway of a complex enzyme.
    Schmidt M; Kloetzel PM
    FASEB J; 1997 Dec; 11(14):1235-43. PubMed ID: 9409542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
    Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
    Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
    J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keepers at the final gates: regulatory complexes and gating of the proteasome channel.
    Bajorek M; Glickman MH
    Cell Mol Life Sci; 2004 Jul; 61(13):1579-88. PubMed ID: 15224182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations on the maturation and regulation of archaebacterial proteasomes.
    Groll M; Brandstetter H; Bartunik H; Bourenkow G; Huber R
    J Mol Biol; 2003 Mar; 327(1):75-83. PubMed ID: 12614609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for the activation of 20S proteasomes by 11S regulators.
    Whitby FG; Masters EI; Kramer L; Knowlton JR; Yao Y; Wang CC; Hill CP
    Nature; 2000 Nov; 408(6808):115-20. PubMed ID: 11081519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteasome.
    Bochtler M; Ditzel L; Groll M; Hartmann C; Huber R
    Annu Rev Biophys Biomol Struct; 1999; 28():295-317. PubMed ID: 10410804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors.
    Myung J; Kim KB; Lindsten K; Dantuma NP; Crews CM
    Mol Cell; 2001 Feb; 7(2):411-20. PubMed ID: 11239469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.
    Yang ZQ; Kwok BH; Lin S; Koldobskiy MA; Crews CM; Danishefsky SJ
    Chembiochem; 2003 Jun; 4(6):508-13. PubMed ID: 12794861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding mode of TMC-95A analogues to eukaryotic 20S proteasome.
    Kaiser M; Groll M; Siciliano C; Assfalg-Machleidt I; Weyher E; Kohno J; Milbradt AG; Renner C; Huber R; Moroder L
    Chembiochem; 2004 Sep; 5(9):1256-66. PubMed ID: 15368577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical analysis of the 20 S proteasome of Trypanosoma brucei.
    Wang CC; Bozdech Z; Liu CL; Shipway A; Backes BJ; Harris JL; Bogyo M
    J Biol Chem; 2003 May; 278(18):15800-8. PubMed ID: 12600991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 26S proteasome of the yeast Saccharomyces cerevisiae.
    Fischer M; Hilt W; Richter-Ruoff B; Gonen H; Ciechanover A; Wolf DH
    FEBS Lett; 1994 Nov; 355(1):69-75. PubMed ID: 7957966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.